Chattaway, Frederick D. et al. published their research in J Chem. Soc. in 1929 | CAS: 5448-43-1

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Quinoxalines are important class of heterocyclic compounds, associated with wider pharmacological applications. The antitumoral properties of quinoxaline compounds have been of interest. Recently, quinoxaline and its analogs have been investigated as the catalyst’s ligands.Formula: C8H5ClN2

Action of o-phenylenediamines upon dihydroxytartaric acid was written by Chattaway, Frederick D.;Humphrey, William G.. And the article was included in J Chem. Soc. in 1929.Formula: C8H5ClN2 This article mentions the following:

When Na dihydroxytartrate is heated with aqueous o-C6H4(NH2)2, 2 mols of the diamine react with 1 mol. only of the salt, forming quinoxaline-2,3-dicarboxy-o-phenylenediamide (I); Na dihydroxytartrate is only very sparingly soluble in H2O and any excess above 1 mol. remains in suspension unchanged. When the filtered alk, solution is partly neutralized with HCl, I seps. as a colorless crystalline powder, stable in neutral solution and dissolving readily in cold dilute aqueous alkali, from which it is reprecipitated on addition of a deficiency of acid. It dissolves in hot dilute HCl (1:50), but on cooling, the o-phenylenediamine salt, (II) of quinxaline-2,3-dicarboxylic acid (III) seps; whereas, if it is dissolved in hot moderatelv concentrated HCl (1:1), III separated on cooling o-phenylenediamine-HCl remaining in solution The II and III may consequently be obtained directly from the original yellow condensation solution, the former by making the solution weakly acid with HCl, and the latter by saturating it with gaseous HCl. Attempts to acetylatc or benzoylate I by the usual methods also cause decomposes, with formation of the di-Ac or the di-Bz derivative of o-C6H4(NH2)2. Heated with Ac2O, III yields the anhydide, while dry NH3 on this anhydride in C6H4 suspensions gives the NH4 salt of 3-carbamylquinoxaline-2-carboxylic acid (IV), from which the acid itself may be obtained on acidification. This amic acid is converted into the corresponding imide (V) on being heated above its m. P., and into the Ac derivative of the imide on boiling with Ac2O. On being heated above its m. p., III decomposes, evolving CO2 and yielding a small quantity (10%) of quinoxaline; better yields (30%) of this base are obtained by heating the NH4 salt of the acid. In common with other N bases, quinoxaline forms a stable, well-crystallized monotetrachloroiodiede. Similarly, Na chloroquinoxaline-2,3-dicarboxy-p-chloro-o-phenylenediamide, from which the p-chloro-o-phenylenediamine salt of 6-chloroquinoxaline-2,3-dicarboxylic acid, and the free acid (VI) are obtained by heating with dilute and with concentrated HCl, resp. p-Bromo-o-phenylenediamine gives the corresponding Br derivative These halogen-substituted derivatives are considerably less soluble than the unsubstituted compounds, and are therefore more readily prepared and purified; otherwise their reactions are analogous. The following compounds were prepared and characterized: I, m. 184° (decomposition). II, lemon-yellow, m. 186° (decomposition). III, prisms containing 2 mols. H2O of crystallization, m. 190° (decomposition after loss of H2O at 110°); Et ester, C14H14O4N2, prisms, m. 83°; NH4 salt, m. 220-30°; anhydride, pale yellow prisms decomposing and charring 250-60°. IV, m. 190-5° (decomposition). V, pale yellow, m. about 260° (decompose); Ac derivative, leaflets, m. about 220° (decomposition). Quinoxaline mono-tetrachloroiodide, C6H4N2. HICl4, m. 125-30° (decomposition). 6-Chlroquinoxaline-2,3-dicarboxy-p-chloro-o-phenylenediamide, C16H8O2N4Cl2, m. 207° (decomposition) (p-chloro-o-phenylenediamine salt, C16H18O4N4Cl3, m. 205° (decomposition)); 6-bromoquinoxaline-2,3-dicarboxy-p-bromo-o-phenylenediamide, m. 198° (decomposition) (p-bromo-o-phenyleneamine salt, m. 199° (decomposition)). VI, m. 175° (decomposition) (anhydride,m. 235-40° (decomposition), Et H ester, m. 159°; di-Et ester, m. 60°; NH4 salt, m. 215-25° (decomposition)). 6-Chloroquinoxaline, m. 60°, 6-Bromoquinoxaline-2,3-dicarboxylic acid, m. 172° (decomposition) (anhydride, m. 235-45° (decomposition), Et H ester, m. 161°, di-Et ester, m. 69°, NH4 salt, m. 235-40° (decomposition)). 6-Bromoquinoxaline, m. 56°. Pyrazinetetracarboxylic acid (by oxidation of the anhydride of III), m. 205° (decomposition), di-K di-H salt is crystalline, tetra-Et ester, m. 104°. In the experiment, the researchers used many compounds, for example, 6-Chloroquinoxaline (cas: 5448-43-1Formula: C8H5ClN2).

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Quinoxalines are important class of heterocyclic compounds, associated with wider pharmacological applications. The antitumoral properties of quinoxaline compounds have been of interest. Recently, quinoxaline and its analogs have been investigated as the catalyst’s ligands.Formula: C8H5ClN2

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Kurhe, Yeshwant et al. published their research in Journal of Pharmacy and Pharmacology in 2014 | CAS: 49679-45-0

Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate

QCM-4 a novel 5-HT3 antagonist attenuates the behavioral and biochemical alterations on chronic unpredictable mild stress model of depression in Swiss albino mice was written by Kurhe, Yeshwant;Radhakrishnan, Mahesh;Gupta, Deepali;Devadoss, Thangaraj. And the article was included in Journal of Pharmacy and Pharmacology in 2014.Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate This article mentions the following:

Objectives: The inconsistent therapeutic outcome necessitates identifying novel compounds for the treatment of depression. Therefore, the present study is aimed at evaluating the antidepressant-like effects of a novel 5-HT3 receptor antagonist 3-methoxy-N-p-tolylquinoxalin-2-carboxamide (QCM-4) on chronic unpredictable mild stress (CUMS) induced behavioral and biochem. alterations in mice. Methods: Animals were subjected to different stressors for a period of 28 days. Thereafter, battery tests like locomotor score, sucrose preference test, forced swim test (FST), tail suspension test (TST), elevated plus maze (EPM) and open field test (OFT) were performed. Biochem. assays like lipid peroxidation, nitrite levels, reduced glutathione (GSH), catalase and superoxide dismutase (SOD) were assessed in brain homogenate. Key findings: QCM-4 dose dependently reversed the CUMS induced behavioral and biochem. alterations by increasing the sucrose consumption, reducing the immobility time in FST and TST, increasing the percent time in open arm in EPM and increasing the ambulation along with the rearings and decreased number of fecal pellets in OFT. Further, biochem. alterations were attenuated by QCM-4 as indicated by reduced lipid peroxidation and nitrite levels and elevated antioxidant enzyme levels like GSH, catalase and SOD. Conclusions: QCM-4 attenuated the behavioral and biochem. derangements induced by CUMS in mice, indicating antidepressant behavior of the novel compound In the experiment, the researchers used many compounds, for example, Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate).

Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Quality Control of Ethyl 3-chloroquinoxaline-2-carboxylate

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Nishimura, Rodolfo H. V. et al. published their research in ChemistrySelect in 2020 | CAS: 5448-43-1

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Computed Properties of C8H5ClN2

Selective Functionalization of Benzo-Fused N-Heterocycles by Using In Situ Trapping Metalations was written by Nishimura, Rodolfo H. V.;Murie, Valter E.;Vessecchi, Ricardo;Clososki, Giuliano C.. And the article was included in ChemistrySelect in 2020.Computed Properties of C8H5ClN2 This article mentions the following:

Some benzo-fused N-heterocycles, e.g., I were prepared by regioselective metalation of quinoline, isoquinoline, quinoxaline and quinazoline with LiTMP in the presence of zinc chloride. Applying this strategy to synthesize an analog of the antitumor verubulin illustrated its relevance for medicinal chem. Computational calculations of the pKa values of the aromatic hydrogens helped to rationalize substrate reactivity and metalation regioselectivity by the complex-induced proximity effect concept. In the experiment, the researchers used many compounds, for example, 6-Chloroquinoxaline (cas: 5448-43-1Computed Properties of C8H5ClN2).

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Compounds possessing quinoxaline derivatives were bestowed with a variety of significant biological properties such as antiviral, antimalarial, anticancer, DNA intercalation, DNA duplex stabilization, and many others. Quinoxalines are used as dyes, pharmaceuticals, and antibiotics such as echinomycin, levomycin exhibiting antitumoral properties. Quinoxalines establish also the basis of anthelmintics and receptor antagonists.Computed Properties of C8H5ClN2

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Zhang, Xia et al. published their research in Organic & Biomolecular Chemistry | CAS: 5448-43-1

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including as well as for RNA synthesis inhibition, reactive dyes and pigments, azo dyes, flurox Cylin Dyes, Corrosion Inhibitors and Photovoltaic Polymers. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.SDS of cas: 5448-43-1

Rhodium-catalyzed transfer hydrogenation of quinoxalines with water as a hydrogen source was written by Zhang, Xia;Chen, Jingchao;Khan, Ruhima;Shen, Guoli;He, Zhenxiu;Zhou, Yongyun;Fan, Baomin. And the article was included in Organic & Biomolecular Chemistry.SDS of cas: 5448-43-1 This article mentions the following:

Rhodium-catalyzed transfer hydrogenation of quinoxalines with water as a hydrogen source is reported. The reaction allows the simple preparation of 1,2,3,4-tetrahydroquinoxalines under mild conditions. The deuterium-labeling experiment confirmed that water is the sole hydrogen source in the transfer hydrogenation reaction. In the experiment, the researchers used many compounds, for example, 6-Chloroquinoxaline (cas: 5448-43-1SDS of cas: 5448-43-1).

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including as well as for RNA synthesis inhibition, reactive dyes and pigments, azo dyes, flurox Cylin Dyes, Corrosion Inhibitors and Photovoltaic Polymers. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.SDS of cas: 5448-43-1

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Pesson, Marcel et al. published their research in Comptes Rendus des Seances de l’Academie des Sciences, Serie C: Sciences Chimiques in 1976 | CAS: 49679-45-0

Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including antibacterial, antibiotic and antineoplastic, antifungal, anti-inflammatory and analgesic drugs. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.SDS of cas: 49679-45-0

1-Alkyl-4-oxo-1,4-dihydropyrido[2,3-b]quinoxaline-3-carboxylic acids with antibacterial action was written by Pesson, Marcel;De Lajudie, Pierre;Antoine, Michel;Chabassier, Simone;Girard, Philippe. And the article was included in Comptes Rendus des Seances de l’Academie des Sciences, Serie C: Sciences Chimiques in 1976.SDS of cas: 49679-45-0 This article mentions the following:

Pyridoquinoxalinecarboxylic acids I (R = H; R1 = Me, Et; R2 = H, Me, Cl, OMe; R3 = H, Me, OMe) were prepared by treating the quinoxalines II (R = Me, Et, R4 = Cl) with R1NHCH2CH2CO2H, esterifying II (R4 = NR1CH2CH2CO2H), cyclizing II (R4 = NR1CH2CH2CO2R), brominating-dehydrobrominating the dihydro derivatives of I (R = Me, Et), and saponifying I (R = Me, Et). I have bactericidal activity, which is reduced by substitution in the 7- or 8-positions. In the experiment, the researchers used many compounds, for example, Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0SDS of cas: 49679-45-0).

Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including antibacterial, antibiotic and antineoplastic, antifungal, anti-inflammatory and analgesic drugs. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.SDS of cas: 49679-45-0

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

McGuire, Ryan T. et al. published their research in ACS Catalysis in 2019 | CAS: 5448-43-1

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the biological results and are endowed with anti-viral, anti-cancer, anti-bacterial, and anti-protozoal activities with application in many other therapeutic areas.Formula: C8H5ClN2

Nickel-Catalyzed C-N Cross-Coupling of Ammonia, (Hetero)anilines, and Indoles with Activated (Hetero)aryl Chlorides Enabled by Ligand Design was written by McGuire, Ryan T.;Paffile, Julia F. J.;Zhou, Yuqiao;Stradiotto, Mark. And the article was included in ACS Catalysis in 2019.Formula: C8H5ClN2 This article mentions the following:

The Ni(II) precatalyst (C1) featuring the phosphonite ancillary ligand Phen-DalPhos (L1) was employed in the cross-coupling of (hetero)anilines with (hetero)aryl chlorides and in the diarylation of ammonia with (hetero)aryl chlorides to afford heteroatom-dense di(hetero)arylamines. The PAd2-DalPhos precatalyst C4 provided complementary reactivity in cross-couplings of indoles with (hetero)aryl chlorides. Taken together, the demonstration of room-temperature reactivity within each of the reaction classes examined and the observation of useful chemoselectivity at low loading (≤0.5 mol % Ni) and on gram-scale distinguishes C1 and C4 from other metal catalysts (i.e., copper, palladium, nickel, or other) within the field of C-N cross-coupling chem. In the experiment, the researchers used many compounds, for example, 6-Chloroquinoxaline (cas: 5448-43-1Formula: C8H5ClN2).

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Condensed heterocycles of quinoxalines have become attractive targets in synthetic and medicinal chemistry due to their significant biological activities. Quinoxaline-1,4-di-N-oxide derivatives have shown to improve the biological results and are endowed with anti-viral, anti-cancer, anti-bacterial, and anti-protozoal activities with application in many other therapeutic areas.Formula: C8H5ClN2

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Lassagne, Frederic et al. published their research in European Journal of Organic Chemistry in 2021 | CAS: 166402-16-0

3-Chloroquinoxalin-6-amine (cas: 166402-16-0) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. The antitumoral properties of quinoxaline compounds have been of interest. Recently, quinoxaline and its analogs have been investigated as the catalyst’s ligands.Name: 3-Chloroquinoxalin-6-amine

Thiazolo[5,4-f]quinoxalines, Oxazolo[5,4-f]quinoxalines and Pyrazino[b,e]isatins: Synthesis from 6-Aminoquinoxalines and Properties was written by Lassagne, Frederic;Sims, Joshua M.;Erb, William;Mongin, Olivier;Richy, Nicolas;El Osmani, Nour;Fajloun, Ziad;Picot, Laurent;Thiery, Valerie;Robert, Thomas;Bach, Stephane;Dorcet, Vincent;Roisnel, Thierry;Mongin, Florence. And the article was included in European Journal of Organic Chemistry in 2021.Name: 3-Chloroquinoxalin-6-amine This article mentions the following:

The regioselective iodination of different 2-mono-, 3-mono- and 2,3-disubstituted 6-aminoquinoxalines, which took place at their 5-position, was rationalized on the basis of Hueckel theory calculations Oxazolo- and thiazolo[5,4-f]quinoxaline analogs of reported disease-related protein kinases inhibitors were synthesized from the obtained 6-amino-5-iodoquinoxalines by using as key step copper-catalyzed azole ring formation. Pyrazino[b,e]isatins were obtained, for the first time, from the same substrates by recourse to Sonogashira coupling, alkyne hydration, and oxidative cyclization. The absorption and emission properties of the most promising compounds were recorded. In addition, most of the synthesized polycycles were evaluated as protein kinase inhibitors and for their antiproliferative activity towards cancer cells. In the experiment, the researchers used many compounds, for example, 3-Chloroquinoxalin-6-amine (cas: 166402-16-0Name: 3-Chloroquinoxalin-6-amine).

3-Chloroquinoxalin-6-amine (cas: 166402-16-0) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. The antitumoral properties of quinoxaline compounds have been of interest. Recently, quinoxaline and its analogs have been investigated as the catalyst’s ligands.Name: 3-Chloroquinoxalin-6-amine

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Binte, Hans J. et al. published their research in Zeitschrift fuer Chemie in 1968 | CAS: 5448-43-1

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Application of 5448-43-1

1,2-Ethylenediols of quinoxaline and 1-phenyl-pyrazolo[o,4-b]quinoxaline was written by Binte, Hans J.;Henseke, Guenter;Bauer, Werner;Koehnke, Kurt. And the article was included in Zeitschrift fuer Chemie in 1968.Application of 5448-43-1 This article mentions the following:

Quinoxaloin (I) was acylated with Ac2O in pyridine to the diacetate, m. 232°, and with BzCl to the dibenzoate, m. 240°. Quinoxaloin diacetate was also obtained directly from quinoxaline-2-carboxaldehyde with Ac2O in pyridine at room temperature I was dehydrated by treatment with air in HCONMe2 to give quinoxalil, m. 248°. Oxidation of I with concentrated HNO3 gave quinoxaline-2-carboxylic acid, m. 212°. Quinoxalil condensed with o-H2NC6H4NH2 in CHCl3 to give 2,3-di(2-quinoxalyl)quinoxaline, m. 231°. R-substituted-quinoxaline-2-carboxaldehydes (II) reacted with KCN in 60% EtOH to give the following R-substituted quinoxaloins (R and m.p. given): 6- or 7-NO2, 297°; 6- or 7-Cl, 290-2°; 6-Cl, 295°; 7-Cl, 292°. II were prepared by HIO4 cleavage of the corresponding R-substituted 2-(D-arabino-tetrahydroxybutyl)quinoxaline. II (R = 6-Cl) formed a yellow phenylhydrazone, m. 197°, while II (R = 6- or 7-NO2) formed a red phenylhydrazone, m. 220-2°. 6(7)-Chloroquinoxaloin gave 6(7), 6′(7)-dichloroquinoxalyl, m. 321-3°, on oxidation with air and 6(7)-chloroquinoxaline-2-carboxylic acid, m. 241°, with HNO3. 7,7′-Dichloro-1,1′-diphenylflavazoin (III), m. 275°, was also prepared; diacetate m. 335-40°; dibenzoate m. 355-60°. It is also dehydrated with air to give isomeric flavazils, m. 300 and 334°. 1,1′-Diphenylflavazoin formed a bis(phenylhydrazone), m. 160°, while the flavazil (m. 300°) formed a monophenylhydrazone, m. 195-8°. The flavazil (m. 300°) reacted with o-H2NC6H4NH2 to give 2,3-bis(1-phenylpyrazolo[3,4-b]quinoxal-3-yl)quinoxaline, m. 283°. Tollens reagent is slowly reduced by I, II, and 1,1′-diphenylflavazoin, while Tillman reagent is reduced almost instantly in acid medium, but not in alk. medium. In the experiment, the researchers used many compounds, for example, 6-Chloroquinoxaline (cas: 5448-43-1Application of 5448-43-1).

6-Chloroquinoxaline (cas: 5448-43-1) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. Modifying quinoxaline structure it is possible to obtain a wide variety of biomedical applications, namely antimicrobial activities and chronic and metabolic diseases treatment.Application of 5448-43-1

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Landquist, Justus K. et al. published their research in Journal of the Chemical Society in 1953 | CAS: 6639-82-3

6-Methoxyquinoxaline (cas: 6639-82-3) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including antibacterial, antibiotic and antineoplastic, antifungal, anti-inflammatory and analgesic drugs. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Application of 6639-82-3

Quinoxaline N-oxides. I. The oxidation of quinoxaline and its Bz-substituted derivatives was written by Landquist, Justus K.. And the article was included in Journal of the Chemical Society in 1953.Application of 6639-82-3 This article mentions the following:

Quinoxaline (I) and its Bz-substituted-alkyl, alkoxy, halo, and acylamino derivatives are oxidized to 1- and 1,4-dioxides by organic peroxy acids. Resistance to N-oxidation is encountered in 5- and 8-substituted I. Reduction of 2,3-(O2N)2C6H3OEt with H and Raney Ni gave 3,1,2-EtOC6H3(NH2)2, oil (picrate, m. 210-12°). 2,4-Br(O2N)C6H3Me nitrated with HNO3 and H2SO4 at 40-5° gave 2,4,5-Br(O2N)2C6H2Me, m. 94-5°, which, treated with NH3 in alc. 5 h. at 120° and then reduced with Zn dust and NaOH in EtOH, yielded the 4,5-(H2N)2 analog, m. 140-1°. The following general procedure for preparation of I derivatives was used: (CHO.NaHSO3)2, an ο-phenylenediamine, and H2O were stirred 3 h. at 60°, then made alk. with KOH, and the I derivative was filtered off. The following derivatives were prepared (substituent, m.p., m.p. of 1-oxide, m.p. of 1,4-dioxide): 5-Me, 20-1°, b15, 120°, 131-2°, 192-4°; 5-EtO, 63-4°, b18 165-6°, 114-16°, -; 5-Cl (II), 60-2°, 177-9°, -; 6-iodo, 114-15°, -, -; 6-NC (III), 176-8°, -, -; 6,7-Me2, 100-1°, -, 220°; 6,7-benzo, 125-6°, -, -; 6,7-ClMe (IV), 120-2°, 166-8°, 227°; 6,7-BrMe (V), 127-8°, 167-8°, 222-4°; 6,7-Cl2 (VI), 210°, -, 206-8°; 5,8-Cl2 (VII), 205-7°, -, -; 6-Br (VIII)(prepared by the Sandmeyer reaction from the 6-NH2 compound), 48-9°, b18 146-9°, -, 223-5°; 6-AcNH (prepared from the 6-NH2 compound with Ac2O), 196.5°, -, 245-7°; 5-AcNH, -, 175-8°, 230-2° (insufficient for anal.). The following N-oxides were also prepared (substituent, m.p. 1-oxide, m.p. 1,4-dioxide): 6-Me (IX), -, 218-19°; 5,6-benzo, 158-9°, 215-16°; 5,6:7,8-dibenzo, 243-4°, -; 5-MeO, -, 222°; 6-MeO, -, 227-8°; 6-EtO, -, 192-4°; 5,6-(MeO)2, 138-40°, 220-2°; 6,7-(MeO)2, -, 264-5°; 2-Cl, 150-2°, -; 6-Cl (X), 151-2°, 211-12°. I is oxidized with equimolar AcO2H to quinoxaline 1-oxide, m. 122-3° (XI) while excess peroxy acid yields quinoxaline 1,4-dioxide, m. 241-3° (XII). Simultaneous with N-oxide formation there were obtained 2,3-dihydroxyquinoxalines which are listed below: (substituent, % yield, m.p.): IX, 1, 112°; II, 30, 142-3°; X, 15-30, 144°; VIII, 28, 132°; VII, 65, 160-1°; VI, 43, 170-70.5°; IV, 10, 172-3°; V, 12-6, 160-1°; III, 50, -; 6-O2N, 60, 150°. XI and MeI in MeCN set aside in the dark 36 h., precipitated 1-methylquinoxalinium iodide 4-oxide, m. 188-9°. XI was added cautiously to POCl3, and the mixture boiled 15 min. after the reaction subsided, poured on ice, made alk. with KOH, extracted with Et2O, and concentrated to yield 2-chloroquinoxaline, m. 46-8°. Under similar conditions XII yielded 2,3-dichloroquinoxaline; 5-methylquinoxaline 1-oxide gave 2-chloro-5-methylquinoxaline, m. 95°; and 5,6-benzoquinoxaline 1-oxide yielded 2-chloro-5,6-benzoquinoxaline, m. 120.5°. 2-C10H7NHCH2CO2Et dissolved treated in EtOH with PhN2Cl yielded 1,2-Ph2NC10H6NHCH2CO2Et, m. 135-6°, hydrogenated with Raney Ni at 60° and 50 atm. to 1,2,3,4-tetrahydro-2-oxo-7,8-benzoquinoxaline (XIII), m. 197-8°. XIII with alk. H2O2 gave 2-hydroxy-7,8-benzoquinoxaline, isolated as the hydrate, m. 275-5.5°, which was converted with POCl3 into 2-chloro-7,8-benzoquinoxaline, m. 128-9°. N-(6-nitro-o-tolyl)glycine in EtOH hydrogenated over Raney Ni at 60° and 60 atm. yielded 1,2,3,4-tetrahydro-5-methyl-2-oxoquinoxaline, m. 177-80°, readily oxidized to 2-hydroxy-5-methylquinoxaline, m. 282-3°. 2-Chloro-7,8-benzoquinoxaline and piperidine refluxed 1.5 h. gave 2-piperidino-7,8-benzoquinoxaline, m. 101.5-2.5°. 2-Piperidino-5,6-benzoquinoxaline, m. 124-5°, was similarly prepared Cl slowly passed 1 h. into 5,6-benzoquinoxaline in glacial HOAc, and the solution filtered and diluted with H2O yielded, on purification, dichloro-5,6-benzoquinoxaline, m. 187-8°. Methylation of 2,3-dihydroxy-6-nitroquinoxaline with Me2SO4 gave 3-hydroxy-1-methyl-6(or 7)-nitro-2(1H)-quinoxalinone, m. 344°. 6(or 7)-Cyano-3-hydroxy-1-methyl-2(1H)-quinoxalinone, m. 353-4°, is similarly prepared In the experiment, the researchers used many compounds, for example, 6-Methoxyquinoxaline (cas: 6639-82-3Application of 6639-82-3).

6-Methoxyquinoxaline (cas: 6639-82-3) belongs to quinoxaline derivatives. Quinoxaline derivatives are important constituents of pharmacologically active compounds, including antibacterial, antibiotic and antineoplastic, antifungal, anti-inflammatory and analgesic drugs. They are well-known for application in organic light emitting devices, polymers and pharmaceutical agents. The quinoxaline-containing polymers are applicable in optical devices due to their thermal stability and low band gap.Application of 6639-82-3

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider

 

Elina, A. S. et al. published their research in Zhurnal Obshchei Khimii in 1955 | CAS: 49679-45-0

Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. Quinoxaline and its analogues may also be formed by reduction of amino acids substituted 1,5-difluoro-2,4-dinitrobenzene (DFDNB),One study used 2-iodoxybenzoic acid (IBX) as a catalyst in the reaction of benzil with 1,2-diaminobenzene.Name: Ethyl 3-chloroquinoxaline-2-carboxylate

N-Oxides of the quinoxaline series. I. N-Oxides of quinoxaline-2-carboxylic acid was written by Elina, A. S.;Magidson, O. Yu.. And the article was included in Zhurnal Obshchei Khimii in 1955.Name: Ethyl 3-chloroquinoxaline-2-carboxylate This article mentions the following:

2-(m-Nitrostyryl)quinoxaline (6.3 g.) heated to boiling in 200 ml. Me2CO, cooled and treated with 5% aqueous KMnO4, filtered (when colorless, the filtrate concentrated and acidified gave mixed acids which treated with 30 ml. 10% NaHCO3 followed by 10 ml. EtOH gave Na quinoxaline-2-carboxylate, which with dilute HCl gave the free acid (I), m. 210-11°, in 56.4% yield; Et ester, m. 83-4°. To 20 g. 2-methylquinoxaline in MePh (240 ml.) was slowly added 18 g. SeO2, the mixture refluxed 1.5 hrs., filtered, the filtrate steam distilled, and the distillate salted out gave quinoxaline-2-carboxaldehyde, which is extracted with Et2O; the pure aldehyde, 56.6%, m. 110° (from petr. ether); the precipitate from the reaction yielded 19.8% I. The aldehyde with thiosemicarbazide in EtOH gave the thiosemicarbazone, decompose 238-9°. The aldehyde treated with KMnO4 in Me2CO gave 72.7% I. I Et ester (4.75 g.) added over 3 hrs. at 45° to 25 ml. AcOH, 19.2 ml. Ac2O, and 23 ml. 30% H2O2 and kept 16 hrs. at 50° gave on neutralization with NaHCO3, 80.1% yellow I 4-oxide Et ester (II), m. 156-7° (from MeOH); similar treatment of I gave I 4-oxide, 80%, m. 180-2° (from EtOH), this substance also being formed in good yield on stirring its Et ester 20 min. with 7.5% NaOH. II and alc. NH3 kept 12 hrs. at room temperature gave I 4-oxide amide, m. 230-30.5° (from EtOH). II in EtOH with 85% N2H4 after 12 hrs. at room temperature gave 90% I 4-oxide hydrazide, m. 216-17° (from 50% EtOH). NH2OH.HCl (1.64 g.) in 9 ml. MeOH treated with 1.97 g. KOH in 29 ml. MeOH, followed, at 40°, by 2 g. II and kept 20 hrs. gave K quinoxaline-2-hydroxamate 4-oxide, yellowish, m. 185-6° (from H2O). To I 4-oxide (0.3 g.) in 3.5 ml. 15% NaOH and 22 ml. H2O was slowly added 0.5 g. Na2S2O4 and after 1 hr. at room temperature the mixture was acidified to Congo red, yielding 83.9% I. II (1 g.) and 10 ml. POCl3 refluxed 1.5 hrs., concentrated, quenched in ice and neutralized, gave Et 3-chloroquinoxaline-2-carboxylate, m. 41.5-2° (cf. Gowenlock, et al., C.A. 40, 341.3), which heated 1.5 hrs. with Na2CO3 in 70% MeOH gave the corresponding free acid, m. 146-7° (decomposition); passage of NH3 in EtOH solution of the Et ester at 0° gave 3-chloroquinoxaline-2-carboxamide, m. 214-15°. To 3 g. 2-methylquinoxaline 1,4-dioxide in C6H6 at reflux was added 3.5 g. SeO2 and after 2 hrs. refluxing, the filtrate yielded 2.02 g. quinoxaline-2-carboxaldehyde 1,4-dioxide, decompose 189-90°, which gives typical aldehyde reactions and liberates iodine from acidic KI solution This on oxidation with 30% H2O2 in AcOH-Ac2O at 50° 1 hr. gave I 1,4-dioxide, yellow, m. 208-9° (from AcOH); this reduced with Na2S2O4 in 5% NaOH at 20-5° to I 1-oxide, colorless, m. 180-1°; this reduced with Na2S2O4 in 3% NaOH to I. In the experiment, the researchers used many compounds, for example, Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0Name: Ethyl 3-chloroquinoxaline-2-carboxylate).

Ethyl 3-chloroquinoxaline-2-carboxylate (cas: 49679-45-0) belongs to quinoxaline derivatives. Quinoxaline is isomeric with other naphthyridines including quinazoline, phthalazine and cinnoline. Quinoxaline and its analogues may also be formed by reduction of amino acids substituted 1,5-difluoro-2,4-dinitrobenzene (DFDNB),One study used 2-iodoxybenzoic acid (IBX) as a catalyst in the reaction of benzil with 1,2-diaminobenzene.Name: Ethyl 3-chloroquinoxaline-2-carboxylate

Referemce:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N2 | ChemSpider